Regional SessionsGuatemala Sessions 2018SOLACI

Guatemala Sessions 2018

solaci
solaci
573
0

35th SOLACI Regional Sessions – 13° Central America and the Caribbean..

June 1st and 2nd, 2018.
Guatemala City, Guatemala.

SOLACI thanks the 210 attendees ─physicians, nurses, technicians and other professionals. Without them, we would not have achieved such scientific success at these regional sessions. 

See the best presentations and pictures of the 2018 Guatemala Sessions

Previous article
Delayed Coronary Obstruction After TAVR: A Complication We Had Not Considered
Next article
Diastolic Dysfunction Should Be Considered in TAVR
solaci
solaci

More articles by this author

Registration Open for Module 2 of the 2026 Annual Course: Multislice CT and Cardiovascular Magnetic Resonance Imaging

solaci - 0
The Latin American Society of Interventional Cardiology (SOLACI) and the Argentine College of Interventional Cardioangiologists (CACI) announce the opening of registration for Module 2...

EuroPCR 2026 | Is localized anticoagulation the next step for coronary stents?

Dr. Juan Manuel Pérez - 0
The DESyne BDS Plus stent was developed as a thin-strut, bioabsorbable polymer drug-eluting stent that combines sirolimus release with two anticoagulant agents (rivaroxaban and...

Esta es una entrada en ingles

solaci - 0
demo en ingles

test eng

solaci - 0

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI

Registration Open for Module 2 of the 2026 Annual Course: Multislice CT and Cardiovascular Magnetic Resonance Imaging

The Latin American Society of Interventional Cardiology (SOLACI) and the Argentine College of Interventional Cardioangiologists (CACI) announce the opening of...
solaci -
SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Inflammation after TAVI: An Emerging Therapeutic Target?

Dr. Juan Manuel Pérez - 0
Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Dr. Andrés Rodríguez - 0
Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Dr. Omar Tupayachi - 0
Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...